Adicet Bio ACET
NASDAQ ACET
$4.28 -0.21 (-4.68%)
At close: Oct 22, 2026 · 4:00 PM EDT

Adicet Bio (ACET) Amortization of Deferred Charges (2020 - 2025)

Updated

Analysis

Adicet Bio (ACET) Amortization of Deferred Charges (2020 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Adicet Bio 40.07 Mn -477.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 15,000.00
Mar 31, 2024 39,000.00
Dec 31, 2023 1,000.00
Sep 30, 2023 1,000.00
Jun 30, 2023 11,000.00
Mar 31, 2023 17,000.00
Dec 31, 2022 74,000.00
Mar 31, 2022 18,000.00
Dec 31, 2021 24,000.00
Sep 30, 2021 51,000.00
Jun 30, 2021 -84,000.00
Mar 31, 2021 184,000.00
Dec 31, 2020 50,000.00
API Access

Adicet Bio Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=ACET&period=max&api_key=YOUR_API_KEY